Dayra Therapeutics: Funding, Investors & Team (Sep 2026)
Dayra Therapeutics manufactures peptide based medicines.
Dayra Therapeutics has raised $20.0M across 1 funding round on record, the most recent an undisclosed round of $20.0M announced in Nov 2025.
That round is in line with the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Dayra Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Dayra Therapeutics Funding Rounds
Dayra Therapeutics Founders and Leadership Team
Contact details for the Dayra Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Dayra Therapeutics Funding Compared to Other Biotechnology Startups
Dayra Therapeutics' latest round of $20.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Dayra Therapeutics in Biotechnology and Cambridge
Companies Similar to Dayra Therapeutics
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Dayra Therapeutics Funding FAQs
What does Dayra Therapeutics do?
Dayra Therapeutics manufactures peptide based medicines.
How much funding has Dayra Therapeutics raised?
Dayra Therapeutics has raised $20.0M across 1 round on record. The most recent is an undisclosed round of $20.0M announced in Nov 2025.
When did Dayra Therapeutics last raise funding?
Dayra Therapeutics' most recent funding round on record is an undisclosed round of $20.0M, announced in Nov 2025.
Where is Dayra Therapeutics headquartered?
Dayra Therapeutics is based in Cambridge, United States.
How many employees does Dayra Therapeutics have?
Dayra Therapeutics is in the 11-50 employee band.
How does Dayra Therapeutics' funding compare to other Biotechnology startups?
Dayra Therapeutics' latest round of $20.0M is in line with the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Dayra Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Dayra Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.